Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
61 hedge funds and large institutions have $22.1M invested in Genesis Healthcare, Inc. in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 17 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 71 → 61 (-10)
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
49% less capital invested
Capital invested by funds: $42.9M → $22.1M (-$20.8M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$1.62M |
| 2 |
State Street
Boston,
Massachusetts
|
+$445K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$174K |
| 4 |
SIM
Spark Investment Management
New York
|
+$170K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$92.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$10.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$4.6M |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
-$885K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$475K |
| 5 |
D.E. Shaw & Co
New York
|
-$215K |
GEN Hedge Fund Activity: Q2 2016 in Review
61 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2016, worth a combined $22.1M — down 49% from $42.9M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of GEN and 8 opened new positions — a net loss of 9 holders — while 23 trimmed existing stakes and 16 added.
The largest buyer was Columbia Pacific Advisors, adding an estimated $1.62M. The largest seller was HighTower Advisors, exiting entirely with an estimated $10.1M sold.
- 61 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2016, down from 71 in Q1 2016.
- Funds reported $22.1M of Genesis Healthcare, Inc. stock for Q2 2016, down 49% quarter-over-quarter.
- 8 funds opened new Genesis Healthcare, Inc. positions in Q2 2016 and 17 closed out, a net change of -9 holders.
- The largest Genesis Healthcare, Inc. buyer in Q2 2016 was Columbia Pacific Advisors, an estimated $1.62M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2016 was HighTower Advisors, an estimated $10.1M sold.
Based on aggregated 13F filings for Q2 2016.